BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to UM-SCC-1 cell line is 88
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCG2 | 74 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-10B | NA | SP assay and SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.1739 | 21344428 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-10B | NA | SP assay and SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.1135 | 21344428 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.1135 | 32773768 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.1135 | 31742606 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.6448 | 32773768 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.6448 | 31742606 |
| SMURF1 | 16807 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-17B | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0011 | 25471937 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.5695 | 32773768 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.5695 | 31742606 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-103 | NA | FACs followed by IF staining and SFA | NA | 0.36 | 1 | 23558285 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-103 | NA | FACs followed by Migration assay | NA | 0.36 | 1 | 24415402 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-103 | NA | SFA followed by FACs | NA | 0.36 | 1 | 25428916 |
| FUT7 | 4018 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-103 | NA | SFA followed by FACs and IF staining | NA | 0.36 | 0.0011 | 23558285 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-103 | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.684 | 25428916 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-103 | NA | FACs followed by SFA | NA | 0.32 | 0.684 | 23558285 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-14B | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.684 | 25428916 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-17B | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 1 | 25471937 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-17B | NA | FACs followed by SFA | NA | 0.32 | 1 | 25471937 |
| NCAM1 | 7656 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-103 | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.0074 | 25428916 |
| NCAM1 | 7656 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-14B | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.0074 | 25428916 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.1135 | 34689150 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.1135 | 34689150 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 1 | 34689150 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | Western Blotting followed by CFA | NA | 0.28 | 1 | 28423495 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | FACs followed by SFA | NA | 0.28 | 1 | 26098778 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | FACs | NA | 0.28 | 1 | 29028842 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | Cisplatin | FACs | NA | 0.28 | 1 | 29861860 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | FACs | NA | 0.28 | 1 | 32066820 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-10B | NA | Western Blotting followed by CFA | NA | 0.28 | 1 | 28423495 |
| EPCAM | 11529 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | Western Blotting followed by CFA | NA | 0.28 | 0.211 | 28423495 |
| EPCAM | 11529 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-10B | NA | Western Blotting followed by CFA | NA | 0.28 | 0.211 | 28423495 |
| IL6R | 6019 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0021 | 34689150 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | Western Blotting followed by CFA | NA | 0.28 | 0.6448 | 28423495 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.6448 | 24533098 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-10B | NA | Western Blotting followed by CFA | NA | 0.28 | 0.6448 | 28423495 |
| SHH | 10848 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | Western Blotting followed by CFA | NA | 0.28 | 0.0201 | 28423495 |
| SHH | 10848 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-10B | NA | Western Blotting followed by CFA | NA | 0.28 | 0.0201 | 28423495 |
| STAT3 | 11364 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0223 | 34689150 |
| STAT3 | 11364 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.0223 | 34689150 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.684 | 32773768 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.684 | 31742606 |
| BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-17B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.1135 | 25471937 |
| CD24 | 1645 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-17B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.456 | 25471937 |
| GLI1 | 4317 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.0308 | 32773768 |
| GLI1 | 4317 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0308 | 31742606 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 24533098 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-103 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 25428916 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | SFA followed by qPCR | NA | 0.2 | 0.5461 | 21304586 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 26323460 |
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-14B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 25428916 |
| NOTCH1 | 7881 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.0477 | 32773768 |
| NOTCH1 | 7881 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0477 | 31742606 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-103 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 25428916 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | SFA followed by qPCR | NA | 0.2 | 0.6448 | 21304586 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 26323460 |
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-14B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 25428916 |
| RHOC | 669 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0032 | 24533098 |
| SMO | 11119 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.0212 | 32773768 |
| SMO | 11119 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0212 | 31742606 |
| SNAI1 | 11128 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0212 | 26323460 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5695 | 24533098 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-103 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5695 | 25428916 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | SFA followed by qPCR | NA | 0.2 | 0.5695 | 21304586 |
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-14B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5695 | 25428916 |
| TWIST1 | 12428 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0191 | 26323460 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 34689150 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | Cisplatin | FACs followed by SFA | NA | 0.12 | 0.684 | 34689150 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | SFA followed by ALDEFLUOR assay | NA | 0.12 | 0.684 | 24533098 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | FACs | NA | 0.12 | 0.684 | 29028842 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | Cisplatin | FACs | NA | 0.12 | 0.684 | 29861860 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-1 | NA | FACs | NA | 0.12 | 0.684 | 32066820 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-104 | NA | ALDEFLUOR assay followed by Tumorigenicity assay | NA | 0.12 | 0.684 | 22162267 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | FACs followed by SFA | NA | 0.12 | 0.684 | 27780858 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | SFA followed by ALDEFLUOR assay | NA | 0.12 | 0.684 | 21304586 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-17A | NA | FACs | NA | 0.12 | 0.684 | 32066820 |
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-17B | NA | FACs followed by SFA | NA | 0.12 | 0.684 | 25471937 |
| CD24 | 1645 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | SFA followed by FACs | NA | 0.12 | 0.456 | 21304586 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | FACs followed by SFA | NA | 0.12 | 1 | 27780858 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | SFA followed by FACs | NA | 0.12 | 1 | 21304586 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | FACs followed by SFA | NA | 0.12 | 1 | 32773768 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | FACs followed by SFA | NA | 0.12 | 1 | 31742606 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-14B | NA | SFA followed by FACs | NA | 0.12 | 1 | 25428916 |
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-17A | NA | FACs | NA | 0.12 | 1 | 32066820 |
| ITGB1 | 6153 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-103 | NA | SFA followed by FACs | NA | 0.12 | 0.018 | 25428916 |
| ITGB1 | 6153 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-14B | NA | SFA followed by FACs | NA | 0.12 | 0.018 | 25428916 |
| NGFR | 7809 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | FACs followed by SFA | NA | 0.12 | 0.018 | 32773768 |
| NGFR | 7809 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-12 | NA | FACs followed by SFA | NA | 0.12 | 0.018 | 31742606 |
| TPBG | 12004 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | UM-SCC-11B | NA | FACs followed by SFA | NA | 0.12 | 0.0032 | 27780858 |